In celebration of National Nurses Week, we take time to honor the men and women who provide extraordinary patient care at Michigan Medicine.
A large study shows bone complications in thyroid cancer are an indicator of a poor prognosis, suggesting the need for more drug research.
University of Michigan Comprehensive Cancer Center experts will discuss breast cancer risks (and how you can reduce yours), as well as screening, treatment and research at a free Breast Cancer Summit on Saturday, May 6, 2017.
Physicians’ misunderstanding of genetic test results may hamper mastectomy decisions for breast cancer patients
A recent survey of over 2,000 women newly diagnosed with breast cancer found that half of those who undergo bilateral mastectomy after genetic testing don’t actually have mutations known to confer increased risk of additional cancers.
The Forbes Institute for Cancer Discovery at the University of Michigan has announced its first round of grant recipients, with $500,000 earmarked to undertake high-risk, high-reward initiatives with the potential to drive new advances in cancer research.
Health coalition forms National Lung Cancer Roundtable to increase screening, reduce lung cancer deaths
The American Cancer Society and a coalition of leading professional, government and non-governmental organizations are coming together to form the National Lung Cancer Roundtable to accelerate the nation’s efforts to reduce mortality from lung cancer.
When small-molecule inhibitors proved elusive, researchers developed a novel strategy: Using large molecule peptides to target a common prostate cancer driver. It may provide a path for developing new therapies against a challenging target.
Revised understanding of graft-versus-host disease origins offers new direction for potential therapies
An international research team led by the University of Michigan Life Sciences Institute is changing the understanding of the key cellular and molecular events that trigger graft-versus-host disease, an often-fatal complication of bone marrow transplants.
Fewer than three out of five women with cervical cancer received guideline-based care, a new study finds. For black and Hispanic women, it’s just over half, which could help explain why cervical cancer outcomes tend to be worse for these women.
It’s well known that women with certain hereditary genetic mutations, particularly BRCA1 and BRCA2, have an increased risk of breast cancer. But in recent years, researchers have discovered a link between some of those same genetic mutations – along with a handful of others – and aggressive prostate cancer.